Dr. Powel Brown, MD

• Medical Oncology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• New York University

  Medical School, 1985

• Low-Dose Aspirin in High-Risk Individuals With Screen-Detected Subsolid Lung Nodules: A Randomized Phase II Trial, 2020-10-20

• Energy balance modulation impacts epigenetic reprogramming, ERa and ERß expression, and mammary tumor development in MMTV-neu transgenic mice, 2017-04-03

• Optimization of erlotinib plus sulindac dosing regimens for intestinal cancer prevention in an Apc-mutant model of Familial Adenomatous Polyposis (FAP), 2020-12-04

• A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions or Benign Breast Disease, 2018-02-16

• Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer, 2023-01-04

• Functional consequence of theMET-T1010I polymorphism in breast cancer, 2014-12-31

• The Combination of Tamoxifen and the Rexinoid LG100268 Prevents ER-Positive and ER-Negative Mammary Tumors in P53-Null Mammary Gland Mice, 2012-08-27

• Targeting nuclear hormone receptors for the prevention of breast cancer, 2023-07-31

• Effect of Zileuton and Celecoxib on Urinary LTE4and PGE-M Levels in Smokers, 2013-05-16

• A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment, 2019-05-17

• Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1, 2020-01-03

• PI4KIIIß is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma, 2020-01-22

• A web-based screening and accrual strategy for a cancer prevention clinical trial in healthy smokers, 2012-07-05

• Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa, 2023-05-03

• Response to Braillon, 2021-01-23

• Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer, 2014-03-25

• Treatment strategies and mechanisms associated with the prevention of NASH-associated HCC by a toll-like receptor 4 inhibitor, 2023-01-04

• Targeted Therapy for Breast Cancer Prevention, 2013-09-23

• Lessons from the Failure to Complete a Trial of Denosumab in Women With a PathogenicBRCA1/2Variant Scheduling Risk-Reducing Salpingo-Oophorectomy, 2022-11-01

• Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression, 2022-06-13

• Natural product ß-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy, 2017-10-24

• Plasma Tocopherols and Risk of Prostate Cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT), 2014-06-24

• Naproxen Chemoprevention Promotes Immune Activation in Lynch Syndrome Colorectal Mucosa, 2020-07-08

• Molecularly Targeted Therapies for p53-mutant Cancers, 2017-06-22

• Prevention and Early Detection of Prostate Cancer, 2014-10-03

• ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors, 2015-06-11

• Identifying Cell Cycle Modulators That Selectively Target ARID1A Deficiency Using High-Throughput Image-Based Screening, 2017-03-15

• Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the pro-inflammatory cytokines IL-6 and IL-8, 2013-04-30